Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Axial Chiral Halogenated Biaryl. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114957103B reveals a novel Rhodium-catalyzed method for axially chiral halogenated biaryl compounds, offering superior enantioselectivity and supply chain reliability for pharmaceutical manufacturing.
Novel Rh-catalyzed C-H activation method for high-purity axial chiral intermediates with superior enantioselectivity and scalable process efficiency.